story of the week
Aspirin for Metabolic Dysfunction–Associated Steatotic Liver Disease Without Cirrhosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA: The Journal of the American Medical Association
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial
JAMA 2024 Mar 19;331(11)920-929, TG Simon, RM Wilechansky, S Stoyanova, A Grossman, LE Dichtel, GM Lauer, KK Miller, Y Hoshida, KE Corey, R Loomba, RT Chung, AT ChanFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.